vs
Jack Henry & Associates（JKHY）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Jack Henry & Associates的1.0倍（$622.0M vs $619.3M），Royalty Pharma plc净利率更高（34.4% vs 20.1%，领先14.3%），Jack Henry & Associates同比增速更快（7.9% vs 4.8%），过去两年Jack Henry & Associates的营收复合增速更高（7.2% vs 4.6%）
Jack Henry & Associates是1976年成立的美国专业金融科技企业，主要面向社区银行、信用合作社等中小型金融机构提供金融科技及支付处理解决方案，同时帮助区域银行与信用合作社管控风险、完成合规申报，优化升级线上银行业务相关服务。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
JKHY vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.0倍
$619.3M
营收增速更快
JKHY
高出3.2%
4.8%
净利率更高
RPRX
高出14.3%
20.1%
两年增速更快
JKHY
近两年复合增速
4.6%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $619.3M | $622.0M |
| 净利润 | $124.7M | $214.2M |
| 毛利率 | 43.3% | — |
| 营业利润率 | 25.7% | 62.4% |
| 净利率 | 20.1% | 34.4% |
| 营收同比 | 7.9% | 4.8% |
| 净利润同比 | 27.4% | 2.9% |
| 每股收益（稀释后） | $1.72 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收JKHYRPRX
| Q4 25 | $619.3M | $622.0M | ||
| Q3 25 | $644.7M | $609.3M | ||
| Q2 25 | $615.4M | $578.7M | ||
| Q1 25 | $585.1M | $568.2M | ||
| Q4 24 | $573.8M | $593.6M | ||
| Q3 24 | $601.0M | $564.7M | ||
| Q2 24 | $559.9M | $537.3M | ||
| Q1 24 | $538.6M | $568.0M |
净利润JKHYRPRX
| Q4 25 | $124.7M | $214.2M | ||
| Q3 25 | $144.0M | $288.2M | ||
| Q2 25 | $127.6M | $30.2M | ||
| Q1 25 | $111.1M | $238.3M | ||
| Q4 24 | $97.8M | $208.2M | ||
| Q3 24 | $119.2M | $544.0M | ||
| Q2 24 | $101.1M | $102.0M | ||
| Q1 24 | $87.1M | $4.8M |
毛利率JKHYRPRX
| Q4 25 | 43.3% | — | ||
| Q3 25 | 45.9% | — | ||
| Q2 25 | 44.1% | — | ||
| Q1 25 | 41.8% | — | ||
| Q4 24 | 42.0% | — | ||
| Q3 24 | 42.9% | — | ||
| Q2 24 | 41.5% | — | ||
| Q1 24 | 39.1% | — |
营业利润率JKHYRPRX
| Q4 25 | 25.7% | 62.4% | ||
| Q3 25 | 28.5% | 70.1% | ||
| Q2 25 | 25.3% | 36.3% | ||
| Q1 25 | 23.7% | 94.0% | ||
| Q4 24 | 21.4% | 60.9% | ||
| Q3 24 | 25.2% | — | ||
| Q2 24 | 22.4% | 50.2% | ||
| Q1 24 | 20.8% | -13.0% |
净利率JKHYRPRX
| Q4 25 | 20.1% | 34.4% | ||
| Q3 25 | 22.3% | 47.3% | ||
| Q2 25 | 20.7% | 5.2% | ||
| Q1 25 | 19.0% | 41.9% | ||
| Q4 24 | 17.1% | 35.1% | ||
| Q3 24 | 19.8% | 96.3% | ||
| Q2 24 | 18.1% | 19.0% | ||
| Q1 24 | 16.2% | 0.8% |
每股收益（稀释后）JKHYRPRX
| Q4 25 | $1.72 | $0.49 | ||
| Q3 25 | $1.97 | $0.67 | ||
| Q2 25 | $1.75 | $0.07 | ||
| Q1 25 | $1.52 | $0.55 | ||
| Q4 24 | $1.34 | $0.46 | ||
| Q3 24 | $1.63 | $1.21 | ||
| Q2 24 | $1.39 | $0.23 | ||
| Q1 24 | $1.19 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $28.2M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $2.2B | $9.7B |
| 总资产 | $3.1B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资JKHYRPRX
| Q4 25 | $28.2M | $618.7M | ||
| Q3 25 | $36.2M | $938.9M | ||
| Q2 25 | $102.0M | $631.9M | ||
| Q1 25 | $39.9M | $1.1B | ||
| Q4 24 | $25.7M | $929.0M | ||
| Q3 24 | $43.2M | $950.1M | ||
| Q2 24 | $38.3M | $1.8B | ||
| Q1 24 | $27.3M | $843.0M |
总债务JKHYRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | $0 | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | $60.0M | $7.6B | ||
| Q1 24 | $250.0M | $6.1B |
股东权益JKHYRPRX
| Q4 25 | $2.2B | $9.7B | ||
| Q3 25 | $2.2B | $9.6B | ||
| Q2 25 | $2.1B | $9.5B | ||
| Q1 25 | $2.0B | $9.8B | ||
| Q4 24 | $2.0B | $10.3B | ||
| Q3 24 | $1.9B | $10.3B | ||
| Q2 24 | $1.8B | $9.8B | ||
| Q1 24 | $1.8B | $9.9B |
总资产JKHYRPRX
| Q4 25 | $3.1B | $19.6B | ||
| Q3 25 | $3.0B | $19.3B | ||
| Q2 25 | $3.0B | $18.3B | ||
| Q1 25 | $2.9B | $17.6B | ||
| Q4 24 | $2.9B | $18.2B | ||
| Q3 24 | $2.9B | $18.0B | ||
| Q2 24 | $2.9B | $17.7B | ||
| Q1 24 | $2.8B | $16.1B |
负债/权益比JKHYRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | 0.00× | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | 0.03× | 0.78× | ||
| Q1 24 | 0.14× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $152.7M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $131.4M | — |
| 自由现金流率自由现金流/营收 | 21.2% | — |
| 资本支出强度资本支出/营收 | 3.4% | — |
| 现金转化率经营现金流/净利润 | 1.22× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $654.2M | — |
8季度趋势，按日历期对齐
经营现金流JKHYRPRX
| Q4 25 | $152.7M | $827.1M | ||
| Q3 25 | $120.6M | $702.6M | ||
| Q2 25 | $327.1M | $364.0M | ||
| Q1 25 | $107.8M | $596.1M | ||
| Q4 24 | $89.6M | $742.5M | ||
| Q3 24 | $116.9M | $703.6M | ||
| Q2 24 | $231.8M | $658.2M | ||
| Q1 24 | $97.6M | $664.6M |
自由现金流JKHYRPRX
| Q4 25 | $131.4M | — | ||
| Q3 25 | $111.7M | — | ||
| Q2 25 | $314.9M | — | ||
| Q1 25 | $96.1M | — | ||
| Q4 24 | $73.0M | — | ||
| Q3 24 | $104.1M | — | ||
| Q2 24 | $208.0M | — | ||
| Q1 24 | $87.7M | — |
自由现金流率JKHYRPRX
| Q4 25 | 21.2% | — | ||
| Q3 25 | 17.3% | — | ||
| Q2 25 | 51.2% | — | ||
| Q1 25 | 16.4% | — | ||
| Q4 24 | 12.7% | — | ||
| Q3 24 | 17.3% | — | ||
| Q2 24 | 37.2% | — | ||
| Q1 24 | 16.3% | — |
资本支出强度JKHYRPRX
| Q4 25 | 3.4% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.8% | — |
现金转化率JKHYRPRX
| Q4 25 | 1.22× | 3.86× | ||
| Q3 25 | 0.84× | 2.44× | ||
| Q2 25 | 2.56× | 12.06× | ||
| Q1 25 | 0.97× | 2.50× | ||
| Q4 24 | 0.92× | 3.57× | ||
| Q3 24 | 0.98× | 1.29× | ||
| Q2 24 | 2.29× | 6.45× | ||
| Q1 24 | 1.12× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
JKHY
| Processing | $273.5M | 44% |
| Private Public Cloud | $202.7M | 33% |
| On Premise Support | $79.0M | 13% |
| Product Deliveryand Service | $64.1M | 10% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
